Alkem (India)

Recent papers from Alkem (India)

1. Treating without harming: An urgent call to action for sustainable inhaler disposal in IndiaLung India · 2026
2. Stress‐Induced Degradation Profiling of Satranidazole Using Stability‐Indicating RP‐HPLC Method and LC–MS CharacterizationBiomedical Chromatography · 2026
3. A highly sensitive LC-MS/MS method for the determination and quantification of four mutagenic nitrosamine impurities in bempedoic acid drug substanceArabian Journal of Chemistry · 2026
4. A to Z of Health: An Evidence-Based Narrative Review of Multivitamin-Multimineral and Nutraceutical SupplementationCureus · 2026
5. Comparison of the Efficacy and Safety of Biosimilar Adalimumab Injection with Innovator Adalimumab in Subjects with Active Ankylosing Spondylitis.2025
6. Assessment of Nitrosamine Impurities in Lurasidone Hydrochloride Using APCI‐LC–MS/MS in MRM Mode for Regulatory Compliance and Stability EvaluationRapid Communications in Mass Spectrometry · 2025
7. Exploring the Effectiveness and Safety of Calcium and Vitamin D Supplementation on Bone Health of Indian Patients: Real-World Multicenter Retrospective StudyInternational Journal of Current Pharmaceutical Research · 2025
8. GLIMPSE study: exploring the effectiveness of glimepiride and metformin combination therapy in newly diagnosed type 2 diabetes in IndiaInternational Journal of Advances in Medicine · 2025
9. Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective StudySouth Asian Journal of Cancer · 2025
10. A Phase 3 Multicenter, Double‐Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal OsteoporosisAging Medicine · 2025
11. Evaluation of the Prevalence, Trends, and Correlates of Low Back Pain in India: A Retrospective Cross-Sectional StudyCureus · 2025
12. Dry Powder Inhaler of Sustained-Release Microspheres Containing Glycyrrhizin: Factorial Design and OptimizationCombinatorial Chemistry & High Throughput Screening · 2025
13. Nimesulide: Critical Appraisal of Safety and Efficacy in Acute PainJournal of the Association of Physicians of India · 2025
14. A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal OsteoporosisJournal of the Association of Physicians of India · 2025
15. Unravelling the risk factors and treatment patterns of dyslipidemia in India (UNICORN study)International Journal of Research in Medical Sciences · 2024
16. Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III TrialJCO Global Oncology · 2024
17. Bilastine Reimagined: A Comprehensive Exploration of Pruritus Management With a Novel AntihistamineCureus · 2024
18. Efficacy and Safety of Biosimilar Ranibizumab (OPTIMAB®) versus Innovator Ranibizumab in Patients with Neovascular (Wet) Age-Related Macular Degeneration: A Double-Blind, Randomized, Multicenter, Phase III StudyClinical ophthalmology · 2024
19. Cefotaxime Versus Ceftriaxone: A Comprehensive Comparative ReviewCureus · 2024
20. Physician perspectives on non-steroidal anti-inflammatory drugs: a comprehensive survey on usage and preferencesInternational Journal of Basic & Clinical Pharmacology · 2024